Compare OCUL & ETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCUL | ETY |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.4B |
| IPO Year | 2014 | N/A |
| Metric | OCUL | ETY |
|---|---|---|
| Price | $15.49 | $15.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $22.56 | N/A |
| AVG Volume (30 Days) | ★ 3.6M | 247.3K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $55,783,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.88 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.79 | $10.59 |
| 52 Week High | $16.44 | $13.46 |
| Indicator | OCUL | ETY |
|---|---|---|
| Relative Strength Index (RSI) | 71.40 | 53.28 |
| Support Level | $11.15 | $15.50 |
| Resistance Level | $16.44 | $15.75 |
| Average True Range (ATR) | 0.74 | 0.24 |
| MACD | 0.45 | 0.03 |
| Stochastic Oscillator | 79.89 | 89.26 |
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.